Delivery Order SPE2DX15D3012-SPE2DX24F8VM4
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$1.4K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $2,866.50, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply product. The contract is a Delivery Order type with a Firm Fixed Price pricing arrangement, and has an ultimate completion date of June 11, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,795.38, is for the delivery of MULTIHANCE 529MG/ML 5S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 30, 2024. This contract award is not designated as a set-aside....
This federal contract award, with a GovTribe ID of SPE2DX15D6028|SPE2DX25FWLUQ, was issued by the Defense Logistics Agency's Medical Supply Chain division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,680.18 firm-fixed-price delivery order is for the supply of MULTIHANCE 529MG/ML 5S, a pharmaceutical product. The contract has an ultimate completion date of June 10, 2025 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a larger...
This contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,771.93, is for the supply of MULTIHANCE 529MG/ML 5S, a pharmaceutical product. The contract has an ultimate completion date of December 1, 2023 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a potential value of $1,719.90 and a completion date of January 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has a history of providing pharmaceutical products and medical supplies to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PROHANCE 279.3 MG/ML VIAL 20ML medical supplies. The contract has a ceiling value of $3,840.40 and an ultimate completion date of November 27, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, as a delivery order contract with a firm fixed price pricing type. The award...
This federal contract award was issued by the Medical Supply Chain, an organization within the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.85, is a Firm Fixed Price Delivery Order for the procurement of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $3,871.30. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 24, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, with a ceiling value of $95,594.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...